DOI QR코드

DOI QR Code

Analysis of the Influential Factors for Metabolic Syndrome on Stenosis after Coronary Angiography

심장동맥조영술 후 협착에 미치는 대사증후군의 영향인자 분석

  • Kim, Gyu-Hee (Department of Radiological Science, Kaya University) ;
  • Ji, Tae-Jeong (Department of Radiological Science, Kaya University)
  • 김규희 (가야대학교 방사선학과) ;
  • 지태정 (가야대학교 방사선학과)
  • Received : 2021.12.24
  • Accepted : 2022.01.27
  • Published : 2022.02.28

Abstract

The study is conducted with the subjects who have under gone coronary angiography to examine the influential factors for the severity of coronary stenosis. Four indicators related to hypertension, diabetes, dyslipidemia, obesity of metabolic syndrome were used as influential factors. As a result of the study, metabolic syndrome such as diabetes and dyslipidemia had 3.3 times and 7.7 times higher chance to lead to 1VD, respectively. In 2VD, diabetes showed 2.9 times higher risk, and dyslipidemia showed 8.5 times higher risk. In 3VD, diabetes was found to be 5 times higher and dyslipidemia was 17.5 times higher in risk. Therefore, it was confirmed that dyslipidemia showed the highest correlation among metabolic syndromes. According to this study, it was confirmed that dyslipidemia and diabetes were closely related to the influential factors for coronary artery stenosis.

Keywords

References

  1. Statistical Office. Statistical Yearbook of Causes of Death in 2019.
  2. Jang JE, Kim JB. Present Situation and the Future Prospect on the Cardiovascular Disease. Korean Journal of Oriental Physiology & Pathology. 2001;15(5):659-63.
  3. Jo JY, Park JY, Han CH. Evaluation of Obesity from BMI and Waist Circumference, and Its Relation with Cardiovascular Risk Factors. Korean Journal of Health Education and Promotion. 2008;25(2):47-59.
  4. Choi DH, Eom WS. Effects of Body Fat and BMI on the Cardiac Risk Factors. KSEP. 2006;15(2):119-25.
  5. Maria A, Taft B, Sharon T. Prevalence of the metabolic syndrome in the United States, 2003-2012. JAMA 2015;313(19):1973-74. https://doi.org/10.1001/jama.2015.4260
  6. Brown AE, Mark W. Genetics of Insulin Resistance and the Metabolic Syndrome. Curr Cardiol Rep. 2016;18:75. https://doi.org/10.1007/s11886-016-0755-4
  7. Shin SH, Lee TY. Associations of Serum Lipid Profiles with Incidence of Ischemic Heart Diseases in Korean Adults: Retrospective Cohort Study. Journal of the Korea Academia-Industrial Cooperation Society. 2012;13(5):2219-31. https://doi.org/10.5762/KAIS.2012.13.5.2219
  8. Lakka HM, David EL, Timo AL, Leo KN, Esko K, Jaakko T, Jukka TS. The metabolic syndrome and total and cardiovascular disease mortality in middle-age men. JAMA. 2002;288(21):P2709-16. https://doi.org/10.1001/jama.288.21.2709
  9. Seoul National University Hospital Medical Information. Coronary Angiography. http://www.snuh.org/health/nMedInfo/nView.do?category=TEST&medid=BA000116. Accessed on August 28, 2021.
  10. Kim DJ, Nam JH, Choi DH, Kim HJ, Kim SK, Kim SH, Lee YM, Ahn CW, Cha BS, Song YD, Lim SK, Kim KR, Lee HC, Huh KB. Insulin Resistance and severity of coronary artery diseases in Patients with Coronary Artery Diseases. The Journal of Korean Diabetes. 2002;26:169-79.
  11. Barbara EK, Ronald K, Kristine EL. Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam. Diabetes Care. 2002;25(10):1790-4. https://doi.org/10.2337/diacare.25.10.1790
  12. Lim YL, Hwang SW, Shim HJ, Oh EH, Jang YS, Cho BL. Prevalence and Risk Factors of the Metabolic Syndrome as Defined by NCEP-ATP III. J Korean Acad Fam Med. 2003;24(2):135-43.
  13. Meigs JB. Epidemiology of the metabolic syndrome. The American Journal of Managed Care. 2002;8(11):283-92.
  14. Kim YK. The impact of metabolic syndrome and its components on pulse wave velocity. Korean Journal of Medicine. 2005;68(2):140-8.
  15. The Korean Society of Hypertension. Hypertension treatment guidelines; 2018.
  16. The Korean Society of Diabetes. Diabetes treatment guidelines; 2021.
  17. The Korean Society of Lipid and Arteriosclerosis. Dyslipidemia treatment guidelines; 2018.
  18. The Korean Society of Obesity. Obesity treatment guidelines; 2018.
  19. Cho JY. Predictive Factors of the Restenosis after Percutaneous Coronary Intervention in Young Korean Patients with Acute Myocardial Infarction. Chonnam National University; 2007.
  20. Choi DH, Eom WS. Effects of Body Fat and BMI on the Cardiac Risk Factors. Exercise Science. 2005;15(2):119-25.
  21. Kim HY, Kim MH. Metabolic Syndrome as a Major Risk Factor for Cardivascular Disease. EWHA WOMANS UNI. Human Ecology & Environmental Institute. 2003;2:183-200.
  22. Kim IS, Han JB, Jang SJ, Jang YI. The Study on the Independent Predictive Factor of Restenosis after Percutaneous Coronary Intervention used Drug-Eluting Stent: Case on MDCT Calcium-Scoring Implementation Patient. Journal of Radiological Science and Technology. 2010;33(1):37-44.